NATALIE BACHYNSKY: Open Payments
NPI 1366840068 · CROCKETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 18 payments from 9 companies in 2025. Trend: 2023 $232 · 2024 $224 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $81 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| PFIZER INC. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Viatris Specialty LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, OTEZLA, ELIQUIS, Kerendia, RELISTOR, REPATHA, FARXIGA, YUPELRI.
Industry payments across TX — which companies pay providers there.
